Literature DB >> 15879001

Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward.

Yun Liu1, Guang-Di Chen, Megan R Lerner, Daniel J Brackett, Rae R Matsumoto.   

Abstract

Sigma receptors have recently been implicated in the actions of cocaine, and antagonists of these receptors prevent many acute and subchronic cocaine effects. A previous study revealed that the immediate early gene fra-2 is up-regulated after cocaine administration, and this effect is prevented by the sigma-1 receptor antagonist BD1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine]. In the present study, the effects of cocaine and BD1063 on the expression of six fos and jun genes were evaluated in mouse brains using cDNA microarrays. Several of these genes were altered by cocaine, but only the alteration in fra-2 was prevented by BD1063. The time courses of fra-2 and sigma-1 receptor gene and protein expression in different brain regions were also determined. Cocaine up-regulated fra-2, which was followed by a later up-regulation of sigma-1 receptors. The cocaine-induced up-regulation of fra-2 and sigma-1 receptor genes and proteins were detected in whole brain, striatum, and cortex, but not in cerebellum. All of these cocaine-induced effects were prevented by BD1063. The interaction between cocaine, fra-2, and sigma-1 receptors involves brain regions that are established components of the neural circuit for reward, suggesting that they may contribute to the enduring changes that underlie the cellular basis of drug abuse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879001     DOI: 10.1124/jpet.105.084525

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.

Authors:  Rae R Matsumoto; Su-Min Li; Jonathan L Katz; William E Fantegrossi; Andrew Coop
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

2.  Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND.

Authors:  Lu Yang; Honghong Yao; Xufeng Chen; Yu Cai; Shannon Callen; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

3.  Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.

Authors:  Takato Hiranita; Maddalena Mereu; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  Neuropsychopharmacology       Date:  2012-11-28       Impact factor: 7.853

4.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 5.  Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Subcell Biochem       Date:  2010

Review 6.  The genetic epidemiology of substance use disorder: A review.

Authors:  Elizabeth C Prom-Wormley; Jane Ebejer; Danielle M Dick; M Scott Bowers
Journal:  Drug Alcohol Depend       Date:  2017-08-01       Impact factor: 4.492

7.  Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.

Authors:  Matthew K Brammer; Deborah L Gilmore; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2006-09-28       Impact factor: 4.432

8.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

Review 9.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.